1. Ahn HS, Lee HJ, Hahn S, et al. Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010; 116:5592–5598.
Article
2. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin. 2008; 58:180–190.
Article
3. Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the sug-gestions? Crit Rev Oncol Hematol. 2001; 40:77–94.
Article
4. Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001; 84:64–71.
Article
5. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed.New York: Springer-Verlag;2002. p. 99–106.
6. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors (UICC). 6th ed.New York: Wiley-Liss;2002.
7. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471–1474.
Article
8. Ha TK, Kim HJ, Kwon SJ. Does the new UICC/AJCC TNM staging system (7th Edition) improve assessing prognosis in gastric cancer compared to the old system (6th Edition)? J Korean Gastric Cancer Assoc. 2009; 9:159–166.
Article
9. An JY, Ha TK, Noh JH, Sohn TS, Kim S. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. Arch Surg. 2009; 144:38–45.
Article
10. Park DJ, Kong SH, Lee HJ, et al. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN). Surgery. 2007; 141:757–763.
Article
11. Lu Y, Liu C, Zhang R, et al. Prognostic significance of subclassification of pT2 gastric cancer: a retrospective study of 847 patients. Surg Oncol. 2008; 17:317–322.
Article
12. Kim JP, Hur YS, Yang HK. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol. 1995; 2:308–313.
Article
13. Shen JY, Kim S, Cheong JH, et al. The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer. 2007; 110:745–751.
Article
14. Kennedy BJ. T N M classification for stomach cancer. Cancer. 1970; 26:971–983.
Article
15. D'Ugo D, Pacelli F, Persiani R, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. World J Surg. 2002; 26:672–677.
16. Kodera Y, Yamamura Y, Shimizu Y, et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg. 1998; 187:597–603.
Article
17. Ahn HS, Lee HJ, Hahn S, et al. Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010; 116:5592–5598.
Article
18. Hermanek P. Prognostic factor research in oncology. J Clin Epidemiol. 1999; 52:371–374.
Article
19. Mayer RJ. Gastrointestinal tract cancer. Fauci AS, Braunwald E, Kasper DL, editors. Harrison's Principles of Internal Medicine. 17th ed.New York: McGraw-Hill;2008. p. 573–580.